Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-05-30 @ 12:07 AM
Study NCT ID:
NCT06115902
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TQB2102-Ib-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None